🚀 ProPicks AI Hits +34.9% Return!Read Now

So-Young tops Q1 revenue estimates, expects Q2 decline

EditorRachael Rajan
Published 05/28/2024, 07:12 AM
© Reuters.
SY
-

BEIJING - So-Young International Inc. (NASDAQ: NASDAQ:SY), a leading online social platform for the medical aesthetics industry in China, reported first quarter earnings that surpassed revenue expectations but forecasts a decline for the second quarter.

The company announced a first quarter revenue of RMB318.3 million ($44.1 million), a 2.6% increase from RMB310.1 million in the same period last year, and above the consensus estimate of RMB300.41 million.

The company's adjusted net income for the first quarter was RMB4.1 million ($0.6 million), marking a turnaround from a non-GAAP net loss of RMB2.8 million in the first quarter of the previous year. This improvement was primarily driven by a 23.3% YoY increase in sales of medical products and maintenance services.

Despite the positive performance in the first quarter, So-Young anticipates a decrease in revenue for the second quarter of 2024, projecting it to be between RMB380 million ($52.6 million) and RMB400 million ($55.4 million). This guidance suggests a decline of 7.8% to 2.9% compared to the same period last year.

The company's CEO, Xing Jin, attributed the first quarter's success to the resilience and adaptability of their business, with growth mainly fueled by the sales of medical products and maintenance services. He also highlighted the company's progress in developing businesses that will drive future growth, such as the expansion of their model clinic network and supply chain business.

So-Young's CFO, Hui Zhao, emphasized the solid progress made by the sales of medical products and maintenance services business, which has increasingly contributed to revenue growth. Zhao also noted the company's commitment to disciplined cost controls to support a sustainable expansion of their bottom line.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.